Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q4 2015 · 10-K
Revenue$570.60M$570.60M−4.6% vs Q4 2014 Net Income$49.50M$49.50M+26.9% vs Q4 2014 EPS Diluted$1.68$1.68+25.4% vs Q4 2014 Gross Profit$308,500,000−2.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$35,952,000−10.6% Free Cash Flowderived$7,965,000+9,613.4% Margins · derivedGross margin54.1%+1.0 pt vs Q4 2014
Operating margin10.4%+2.0 pt vs Q4 2014
Net margin8.7%+2.2 pt vs Q4 2014
ended Dec 31, 2015 · filed Feb 29, 2016 · 60 d after period end